Gyula Végső - Search Results

Year	Number of Results
2004	1
2006	1
2007	4
2008	1
2009	1
2010	1
2011	3
2012	3
2013	2
2015	1
2016	1
2017	1
2018	3
2019	3
2022	2
2024	1

1

[Surgical treatment of secondary liver malignancies].

Végsõ G, Fekete L, Fehérvári I, Máthé Z. Végsõ G, et al. Magy Onkol. 2018 Mar 23;62(1):29-36. Epub 2018 Jan 31. Magy Onkol. 2018. PMID: 29570184 Free article. Review. Hungarian.

2

[Liver transplantation in the treatment of hepatic tumors].

Fehérvári I, Piros L, Végsõ G, Máthé Z. Fehérvári I, et al. Among authors: vegso g. Magy Onkol. 2018 Mar 23;62(1):26-28. Epub 2018 Jan 29. Magy Onkol. 2018. PMID: 29570183 Free article. Review. Hungarian.

3

Oncological Screening of Kidney Tumors After Renal Transplantation.

Kiss G, Székely B, Farkas ÁZ, Földes-Lénárd Z, Takács S, Kiss R, Remport Á, Végső G. Kiss G, et al. Among authors: vegso g. Transplant Proc. 2022 Nov;54(9):2589-2592. doi: 10.1016/j.transproceed.2022.10.047. Epub 2022 Nov 14. Transplant Proc. 2022. PMID: 36396469

4

Lymphoproliferative disorders after solid organ transplantation-classification, incidence, risk factors, early detection and treatment options.

Végso G, Hajdu M, Sebestyén A. Végso G, et al. Pathol Oncol Res. 2011 Sep;17(3):443-54. doi: 10.1007/s12253-010-9329-8. Epub 2010 Dec 31. Pathol Oncol Res. 2011. PMID: 21193979 Free article. Review.

5

Role of organ transplantation in the treatment of malignancies: hepatocellular carcinoma as the most common tumour treated with transplantation.

Végso G, Görög D, Fehérvári I, Nemes B, Doros A, Langer RM, Kóbori L. Végso G, et al. Pathol Oncol Res. 2012 Jan;18(1):1-10. doi: 10.1007/s12253-011-9441-4. Epub 2011 Sep 7. Pathol Oncol Res. 2012. PMID: 21901276 Free article. Review.

6

[Malignant tumors following renal transplantation].

Végso G, Járay J. Végso G, et al. Orv Hetil. 2007 Nov 11;148(45):2115-23. doi: 10.1556/OH.2007.28238. Orv Hetil. 2007. PMID: 17984022 Review. Hungarian.

7

Metabolic Adaptation as Potential Target in Papillary Renal Cell Carcinomas Based on Their In Situ Metabolic Characteristics.

Krencz I, Vetlényi E, Dankó T, Petővári G, Moldvai D, Sztankovics D, Raffay R, Mészáros K, Sebestyén E, Végső G, Pápay J, Sebestyén A. Krencz I, et al. Among authors: vegso g. Int J Mol Sci. 2022 Sep 13;23(18):10587. doi: 10.3390/ijms231810587. Int J Mol Sci. 2022. PMID: 36142502 Free PMC article.

8

Oncological Screening of Kidney Transplant Patients: The Role of Ultrasound Examination.

Kiss G, Korda D, Szabó G, Juhász R, Wagner L, Máthé Z, Doros A, Végső G. Kiss G, et al. Among authors: vegso g. Transplant Proc. 2019 May;51(4):1231-1233. doi: 10.1016/j.transproceed.2019.04.016. Transplant Proc. 2019. PMID: 31101203

9

Molecular profiling of parathyroid hyperplasia, adenoma and carcinoma.

Árvai K, Nagy K, Barti-Juhász H, Peták I, Krenács T, Micsik T, Végső G, Perner F, Szende B. Árvai K, et al. Among authors: vegso g. Pathol Oncol Res. 2012 Jul;18(3):607-14. doi: 10.1007/s12253-011-9483-7. Epub 2011 Dec 24. Pathol Oncol Res. 2012. PMID: 22198862 Free article.

10

Tofisopam inhibits the pharmacokinetics of CYP3A4 substrate midazolam.

Tóth M, Drabant S, Varga B, Végso G, Cseh A, Szentpéteri I, Klebovich I. Tóth M, et al. Among authors: vegso g. Eur J Clin Pharmacol. 2008 Jan;64(1):93-4. doi: 10.1007/s00228-007-0397-y. Epub 2007 Nov 8. Eur J Clin Pharmacol. 2008. PMID: 17989974 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

22 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year